Epizyme Obtains $8,000,000 Series B Financing

  • Feed Type
  • Date
    12/8/2009
  • Company Name
    Epizyme
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    Epizyme is a biopharmaceutical company located in Cambridge, MA. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future.
  • Website
    http://www.epizyme.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    “By raising more capital now, we can continue to aggressively advance our pipeline of histone methyltransferase inhibitors for various oncology indications. I look forward to working with our investors to continue to build a leading company in the promising new area of epigenetics.”
  • M&A Terms
  • Venture Investor
    New Enterprise Associates

By posting a comment, you agree to our terms and conditions.